NVO
$NVO
Novo Nordisk A/S
Danish pharma giant behind Ozempic and Wegovy weight-loss treatments.
Healthcare$50.43
+1.66 (+3.40%)
Day Range$49.78 - $50.90
Prev Close$48.77
Analyst Rating
Hold
12 Buy / 23 Hold / 2 Sell
Subscribers
2
Tracking this ticker
Next Report
—
Weekly updates
Latest Report
This week's analysis
NVO: Valuation Reset Amid Demand Shift
Novo Nordisk ($NVO) is trading at deeply discounted multiples and a high dividend yield following a sharp re-rating. Fundamentals remain strong, but weakening obesity drug demand and data inconsistencies leave the outlook mixed.
Mar 30, 2026